Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1456

1.

Belching: dyspepsia or gastroesophageal reflux disease?

Lin M, Triadafilopoulos G.

Am J Gastroenterol. 2003 Oct;98(10):2139-45.

PMID:
14572558
2.

Features of gastroesophageal reflux disease in women.

Lin M, Gerson LB, Lascar R, Davila M, Triadafilopoulos G.

Am J Gastroenterol. 2004 Aug;99(8):1442-7.

PMID:
15307857
3.
4.

Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial.

Johnson DA, Ganz R, Aisenberg J, Cohen LB, Devière J, Foley TR, Haber GB, Peters JH, Lehman GA.

Am J Gastroenterol. 2003 Sep;98(9):1921-30.

PMID:
14499767
5.

Globus sensation caused by gastroesophageal reflux disease.

Tokashiki R, Yamaguchi H, Nakamura K, Suzuki M.

Auris Nasus Larynx. 2002 Oct;29(4):347-51.

PMID:
12393039
6.

Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.

Watson TJ, Peters JH.

Thorac Surg Clin. 2005 Aug;15(3):405-15. Review.

PMID:
16104131
7.

Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?

Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.

Am J Gastroenterol. 2008 Oct;103(10):2446-53. doi: 10.1111/j.1572-0241.2008.02033.x. Epub 2008 Aug 5.

PMID:
18684197
8.

The role of esophageal pH monitoring in symptomatic patients on PPI therapy.

Charbel S, Khandwala F, Vaezi MF.

Am J Gastroenterol. 2005 Feb;100(2):283-9.

PMID:
15667483
9.

An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.

Sharma N, Agrawal A, Freeman J, Vela MF, Castell D.

Clin Gastroenterol Hepatol. 2008 May;6(5):521-4. doi: 10.1016/j.cgh.2008.01.006. Epub 2008 Mar 20.

PMID:
18356117
10.
11.

Air swallowing, belching, acid and non-acid reflux in patients with functional dyspepsia.

Conchillo JM, Selimah M, Bredenoord AJ, Samsom M, Smout AJ.

Aliment Pharmacol Ther. 2007 Apr 15;25(8):965-71.

13.

Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.

Bansal A, Wani S, Rastogi A, Rastogi K, Goyal A, Hall S, Singh V, Higbee A, Sharma P.

Am J Gastroenterol. 2009 Dec;104(12):2918-25. doi: 10.1038/ajg.2009.506. Epub 2009 Sep 15.

PMID:
19755975
16.

Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.

Dekel R, Martinez-Hawthorne SD, Guillen RJ, Fass R.

J Clin Gastroenterol. 2004 Jan;38(1):24-9.

PMID:
14679323
17.

[Postoperative evaluation of esophageal mucosal change dynamics in patients with reflux diseases].

Wallner G, Misiuna P, Chibowski D, Polkowski W, Abramowicz K, Sory A.

Wiad Lek. 1997;50 Suppl 1 Pt 1:273-81. Polish.

PMID:
9446369
18.

Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G.

Dis Esophagus. 2013 Jul;26(5):443-50. doi: 10.1111/j.1442-2050.2012.01381.x. Epub 2012 Aug 2.

PMID:
22862422
19.

Can the combination of symptoms and endoscopy confirm the presence of gastroesophageal reflux disease?

Tefera L, Fein M, Ritter MP, Bremner CG, Crookes PF, Peters JH, Hagen JA, DeMeester TR.

Am Surg. 1997 Oct;63(10):933-6.

PMID:
9322676
20.

Outcomes of laparoscopic antireflux procedures.

Eubanks TR, Omelanczuk P, Richards C, Pohl D, Pellegrini CA.

Am J Surg. 2000 May;179(5):391-5.

PMID:
10930488

Supplemental Content

Support Center